Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.
Document Type
Journal Article
Publication Date
12-19-2017
Journal
Proceedings of the National Academy of Sciences of the United States of America
Volume
114
Issue
51
Inclusive Pages
E10981-E10990
DOI
10.1073/pnas.1712514114
APA Citation
Stone, M., Chiappinelli, K., Li, H., Murphy, L., Travers, M., Topper, M., & +several additional authors (2017). Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.. Proceedings of the National Academy of Sciences of the United States of America, 114 (51). http://dx.doi.org/10.1073/pnas.1712514114
Peer Reviewed
1
